Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2000 Feb;49(2):174-9.
doi: 10.1046/j.1365-2125.2000.00126.x.

Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice

N Freemantle  1 , R Johnson, J Dennis, A Kennedy, M Marchment
Affiliations
Clinical Trial

Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice

N Freemantle et al. Br J Clin Pharmacol. 2000 Feb.

Abstract

Aims: To evaluate the effectiveness of a health authority/pharmaceutical company collaborative intervention to influence the choice of proton pump inhibitors

Methods: Randomized controlled trial, with general practices forming the unit of allocation and analysis.

Results: Constructive working relationships were achieved with five of six pharmaceutical companies involved. One hundred and two out of 140 practitioners in intervention group practices received at least one visit from an industry representative. There were no reports of representatives operating outside their agreed remit. Prescribing in both the intervention and control group moved towards that recommended by the guidelines but there was no difference between the groups in either the proportion of prescriptions in line with the guidelines or the overall cost.

Conclusions: Health authorities can achieve professional working relationships with the pharmaceutical industry although no changes in practice attributable to the intervention are achieved. Further work is required to develop effective means to influence prescribing in line with independent guidelines especially in the context of the development of Primary Care Groups.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Odds ratio and 95% confidence intervals describing the predictive value of the effects of the intervention, and of prior prescribing.
See this image and copyright information in PMC

References

    1. Effective Health Care. Implementing Clinical Practice Guidelines. Leeds: University of Leeds; 1994. Bulletin No 8.
    1. Freemantle N, Mason JM, Watt I. Evidence into practice? Prescribing selective serotonin reuptake inhibitors. Int J Technol Assessment Health Care. 1998;14:387–391. - PubMed
    1. Eccles M, Freemantle N, Mason JM. for the North of England Evidence Based Guideline Development Project. Evidence based clinical practice guideline: angiotensin converting-inhibitors in the primary care management of adults with symptomatic heart failure. Br Med J. 1998;316:1369–1375. - PMC - PubMed
    1. Maynard A, Bloor K. Managed Care: Panacea or palliation? London: Nuffield Trust; 1998. Nuffield Occasional Papers Health Economics Series. Paper No 8.
    1. Liddell A. Commercial approaches to the NHS regarding disease management packages. Vol. 94. Leeds: NHS Executive; 1994. EL (94)

Publication types

MeSH terms

Substances